id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
706,,,,,,,,,,,,,,,2024-06-11T11:10:56+06:00,BSH - H12102146013,B/Lateral,Palbociclib and Letrozole,,,"Completed 6 cycles NACT with EC > Now on Anastrozole from 2018> No won Palbociclib
and Letrozole",,,2023-11-12,,,,,Breast,257,Upper middle class,BSBSC-240000257,NORJAHAN BEGUM,1845159750,1955-02-01,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,2nd Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Bilateral,,,,Alive,,,,,,,,,,,,,,,,,,CA15.3,18.6,,2021-02-28,706.0
265,,,,,,,,,,,,,,,2024-06-11T11:10:56+06:00,BSH - H12102146013,B/Lateral,Palbociclib and Letrozole,,,"Completed 6 cycles NACT with EC > Now on Anastrozole from 2018> No won Palbociclib
and Letrozole",,,2023-11-12,,,,,Breast,257,Upper middle class,BSBSC-240000257,NORJAHAN BEGUM,1845159750,1955-02-01,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,2nd Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Bilateral,,,,Alive,,,,,,,,,,,,,,,,,,,,,,
